Clinical Trial Update: Crossover Study to Compare the Pharmacokinetics and Bioavailability of a Novel Furosemide Regimen Administered Subcutaneously vs. the Same Dose Administered Intravenously in Subjects With Chronic Heart Failure [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 crossover trial assessing pharmacokinetics and bioavailability of a subcutaneous versus intravenous furosemide regimen in chronic heart failure patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• FUROSEMIDE (Furosemide)

Snippet

Sponsor: scPharmaceuticals, Inc. | Conditions: Heart Failure | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2022-12-02